These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 35955495)

  • 1. Statins Neuromuscular Adverse Effects.
    Attardo S; Musumeci O; Velardo D; Toscano A
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular Complications of Statin Therapy.
    Crisan E; Patil VK
    Curr Neurol Neurosci Rep; 2020 Aug; 20(10):47. PubMed ID: 32839913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment.
    Chatzizisis YS; Koskinas KC; Misirli G; Vaklavas C; Hatzitolios A; Giannoglou GD
    Drug Saf; 2010 Mar; 33(3):171-87. PubMed ID: 20158283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular complications of statins.
    Ahn SC
    Phys Med Rehabil Clin N Am; 2008 Feb; 19(1):47-59, vi. PubMed ID: 18194749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suggested clinical approach for the diagnosis and management of 'statin intolerance' with an emphasis on muscle-related side-effects.
    Sivashanmugarajah A; Fulcher J; Sullivan D; Elam M; Jenkins A; Keech A
    Intern Med J; 2019 Sep; 49(9):1081-1091. PubMed ID: 31507054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins, myalgia, and rhabdomyolysis.
    Tournadre A
    Joint Bone Spine; 2020 Jan; 87(1):37-42. PubMed ID: 30735805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myopathies under therapy with lipid-lowering agents].
    Köller H; Neuhaus O; Schroeter M; Hartung HP
    Nervenarzt; 2005 Feb; 76(2):212-7. PubMed ID: 15609055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Statin Intolerance in 2018: Still More Questions Than Answers.
    Toth PP; Patti AM; Giglio RV; Nikolic D; Castellino G; Rizzo M; Banach M
    Am J Cardiovasc Drugs; 2018 Jun; 18(3):157-173. PubMed ID: 29318532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin-induced myopathies.
    Tomaszewski M; Stępień KM; Tomaszewska J; Czuczwar SJ
    Pharmacol Rep; 2011; 63(4):859-66. PubMed ID: 22001973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin induced myotoxicity.
    Sathasivam S
    Eur J Intern Med; 2012 Jun; 23(4):317-24. PubMed ID: 22560377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and myotoxicity: a therapeutic limitation.
    Tiwari A; Bansal V; Chugh A; Mookhtiar K
    Expert Opin Drug Saf; 2006 Sep; 5(5):651-66. PubMed ID: 16907655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype standardization for statin-induced myotoxicity.
    Alfirevic A; Neely D; Armitage J; Chinoy H; Cooper RG; Laaksonen R; Carr DF; Bloch KM; Fahy J; Hanson A; Yue QY; Wadelius M; Maitland-van Der Zee AH; Voora D; Psaty BM; Palmer CN; Pirmohamed M
    Clin Pharmacol Ther; 2014 Oct; 96(4):470-6. PubMed ID: 24897241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iatrogenic myopathies.
    Mastaglia FL
    Curr Opin Neurol; 2010 Oct; 23(5):445-9. PubMed ID: 20581681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins and the neuromuscular system: a neurologist's perspective.
    Argov Z
    Eur J Neurol; 2015 Jan; 22(1):31-6. PubMed ID: 25495398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of Statins and Nonstatins for Treatment of Dyslipidemia.
    Newman CB
    Endocrinol Metab Clin North Am; 2022 Sep; 51(3):655-679. PubMed ID: 35963634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Statin associated myopathy in clinical practice. Results of DAMA study].
    Millán J; Pedro-Botet J; Climent E; Millán J; Rius J
    Clin Investig Arterioscler; 2017; 29(1):7-12. PubMed ID: 27717598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.
    Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J
    Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin-associated myopathy.
    Thompson PD; Clarkson P; Karas RH
    JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of xanthine oxidase to prevent statin-induced myalgia and rhabdomiolysis.
    Alis R; Sanchis-Gomar F; Risso-Ballester J; Perez-Quilis C; Cortell-Ballester J; Romagnoli M; Blesa JR; Emanuele E
    Atherosclerosis; 2015 Mar; 239(1):38-42. PubMed ID: 25568951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
    Harper CR; Jacobson TA
    Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.